Birch Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Sell
3,708
-97
-3% -$6.13K 0.11% 118
2026
Q2
$219K Buy
3,805
+72
+2% +$4.13K 0.11% 128
2026
Q1
$226K Buy
+3,733
New +$218K 0.13% 123
2025
Q2
– Sell
-3,637
Closed -$222K – 117
2025
Q1
$222K Buy
+3,637
New +$212K 0.2% 95

Other funds holding BMY

Birch Financial Group's BMY Position: Q3 2026 in Review

Birch Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q3 2026, selling an estimated $6.13K and leaving 3,708 shares worth $231K. The position accounts for 0.11% of the portfolio, ranked #118.

Birch Financial Group first reported a position in BMY in Q1 2025 and has held it in 4 quarters since. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Birch Financial Group held 3,708 shares of Bristol-Myers Squibb worth $231K as of Q3 2026.
  • Birch Financial Group sold 97 Bristol-Myers Squibb shares in Q3 2026, an estimated $6.13K.
  • Bristol-Myers Squibb made up 0.11% of Birch Financial Group's portfolio in Q3 2026, its #118 holding.
  • Birch Financial Group first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 4 quarters since.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Birch Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.